Belmont Global Advisors’s Novartis NVS Stock Holding History

Belmont Global Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,576	Closed	-$403K	–	71
2015 Q2	$403K	Buy	+4,576	New	+$420K	0.45%	65

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Belmont Global Advisors's NVS Position: Q3 2015 in Review

Belmont Global Advisors sold out of Novartis (NVS) in Q3 2015, closing a stake of 4,576 shares — an estimated $403K sold.

Belmont Global Advisors first reported a position in NVS in Q2 2015 and held it in 1 quarter. The position peaked at $403K in Q2 2015. 925 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

Belmont Global Advisors reported no remaining Novartis position as of Q3 2015 after selling out during the quarter.
Belmont Global Advisors sold 4,576 Novartis shares in Q3 2015, an estimated $403K.
Belmont Global Advisors first reported a position in Novartis in Q2 2015 and held it in 1 quarter.
Belmont Global Advisors's Novartis position peaked at $403K in Q2 2015.
925 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Belmont Global Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.